14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
SNYR vs CAH: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Cardinal Health, Inc. (CAH) is the stronger overall head-to-head candidate over Synergy CHC Corp. (SNYR) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). SNYR carries a Unified Composite Score of 48.9/100 (HOLD) at $0.09 (0.6x Forward P/E, -10.3% operating margin), whereas CAH carries 42.7/100 (HOLD) at $272.81 (22.6x Forward P/E, 1.3% operating margin).
Composite vs. Pillar Nuance: While SNYR currently prints a higher short-term Unified Composite Score (48.9/100 HOLD vs. CAH 42.7/100 HOLD), CAH captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (1.3% vs. -10.3% operating margin) and revenue trajectory (+5.5% vs. -32.8% YoY).
Competes within the Medical Distribution value chain with $62.9B market capitalization and 1.3% operating margin.
OpEx & R&D Reinvestment2.6% of Rev ($6.70B)
90D Engineering Disclosures0 Published
Investor FAQ SNYR vs CAH Key Questions & Quantitative Answers
As of Nov 20, 2026, Cardinal Health, Inc. (CAH) is the stronger overall head-to-head candidate over Synergy CHC Corp. (SNYR) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). SNYR carries a Unified Composite Score of 48.9/100 (HOLD) at $0.09 (0.6x Forward P/E, -10.3% operating margin), whereas CAH carries 42.7/100 (HOLD) at $272.81 (22.6x Forward P/E, 1.3% operating margin). Composite vs. Pillar Nuance: While SNYR currently prints a higher short-term Unified Composite Score (48.9/100 HOLD vs. CAH 42.7/100 HOLD), CAH captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (1.3% vs. -10.3% operating margin) and revenue trajectory (+5.5% vs. -32.8% YoY).
CAH leads the Growth & Scale pillar: SNYR posts -32.8% YoY revenue growth and -90.6% YoY earnings growth on $28M TTM revenue (65.4% gross margin, -10.3% operating margin), compared with CAH at +5.5% YoY revenue growth and +26.6% YoY earnings growth on $257.8B TTM revenue (3.9% gross margin, 1.3% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), SNYR cumulative revenue shifted +0.0% while CAH shifted +74.7%. In operating R&D and SG&A reinvestment, SNYR deploys 75.7% of Rev ($21M) (0 90-day corporate R&D disclosures) versus 2.6% of Rev ($6.70B) (0 disclosures) for CAH.
SNYR screens cheaper on headline valuation multiples. SNYR trades at 0.6x Forward P/E, 0.6x Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-13.7% FCF margin), whereas CAH trades at 22.6x Forward P/E, 35.2x Trailing P/E, 1.31x PEG, and 0.3x EV/Revenue (1.9% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SNYR (-361.1% ROE) versus CAH (0.0% ROE) capital efficiency.
In options market volatility and institutional positioning, SNYR carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.86β · 868% Vol realized risk). By comparison, CAH carries 82.4% implied volatility (59th %ile, Balanced (25th–60th %ile)), a 1.00x (Balanced) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKOUT options structure phase (-0.03β · 24% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.